aid: alkeuspharmaceuticals

name: Alkeuspharmaceuticals

image: https://alkeuspharma.com/wp-content/uploads/2024/12/alkeus-og-logo-yoast.jpg

description: 'Alkeus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies to preserve sight for patients with retinal diseases. Recently acquired by Tarsus Pharmaceuticals, Alkeus continues its research in disease areas such as geographic atrophy and other degenerative eye conditions, advancing clinical trials and scientific collaborations to bring novel treatments to market.'

url: https://raw.githubusercontent.com/api-evangelist/alkeuspharmaceuticals/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-05 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-09-24'

modified: '2026-09-24'

tags:
- Biotechnology
- Pharmaceuticals
- RetinalDisease
- ClinicalTrials
- VisionHealth

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/alkeuspharmaceuticals-hosts.yml
- type: Vendors
  url: vendors/alkeuspharmaceuticals-vendors.yml
- type: TermsOfService
  url: https://alkeuspharma.com/terms-of-use/
- type: PrivacyPolicy
  url: https://alkeuspharma.com/privacy-policy/
- type: Newsroom
  url: https://alkeuspharma.com/news/
- type: DomainSecurity
  url: security/alkeuspharmaceuticals-domain-security.yml
- type: Website
  url: https://alkeuspharma.com

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  detail: The company provides no public developer program or API documentation.
  evidence:
    - url: https://alkeuspharma.com
      status: 200
  checked: '2026-10-05'
x-enrichment:
  date: '2026-10-05'
  status: enriched
  artifacts_added: 8
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local